PKLR
ایزوزیم راست/چپ پیرووات کیناز (انگلیسی: Pyruvate kinase isozymes R/L) یک آنزیم است که در انسان توسط ژن «PKLR» کدگذاری میشود.[۴][۵]
پروتئین حاصله از این ژن یک پیرووات کیناز است که ساخت پیرووات و ATP را از فسفوئنولپیرووات سبب میشود. نقص در این آنزیم، یکی از دلایل شایع «کمخونی همولیتیک غیراسفروسیتی ارثی» است.
منابع
- ↑ ۱٫۰ ۱٫۱ ۱٫۲ GRCm38: Ensembl release 89: ENSMUSG00000041237 - Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Tani K, Fujii H, Tsutsumi H, Sukegawa J, Toyoshima K, Yoshida MC, Noguchi T, Tanaka T, Miwa S (Apr 1987). "Human liver type pyruvate kinase: cDNA cloning and chromosomal assignment". Biochem Biophys Res Commun. 143 (2): 431–8. doi:10.1016/0006-291X(87)91372-6. PMID 3566732.
- ↑ "Entrez Gene: PKLR pyruvate kinase, liver and RBC".
- مشارکتکنندگان ویکیپدیا. «PKLR». در دانشنامهٔ ویکیپدیای انگلیسی، بازبینیشده در ۲۰ اکتبر ۲۰۱۸.
بیشتر بخوانید
- Beutler E, Baronciani L (1996). "Mutations in pyruvate kinase". Hum. Mutat. 7 (1): 1–6. doi:10.1002/(SICI)1098-1004(1996)7:1<1::AID-HUMU1>3.0.CO;2-H. PMID 8664896.
- Baronciani L, Bianchi P, Zanella A (1999). "Hematologically important mutations: red cell pyruvate kinase (2nd update)". Blood Cells Mol. Dis. 24 (3): 273–9. doi:10.1006/bcmd.1998.0193. PMID 10087985.
- Zanella A, Fermo E, Bianchi P, et al. (2007). "Pyruvate kinase deficiency: the genotype-phenotype association". Blood Rev. 21 (4): 217–31. doi:10.1016/j.blre.2007.01.001. PMID 17360088.
- Kanno H, Fujii H, Miwa S (1992). "Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells". Biochem. Biophys. Res. Commun. 188 (2): 516–23. doi:10.1016/0006-291X(92)91086-6. PMID 1445295.
- Kanno H, Fujii H, Hirono A, et al. (1992). "Identical point mutations of the R-type pyruvate kinase (PK) cDNA found in unrelated PK variants associated with hereditary hemolytic anemia". Blood. 79 (5): 1347–50. PMID 1536957.
- Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317–20. doi:10.1016/S0163-4453(05)80037-4. PMID 1602151.
- Kanno H, Fujii H, Hirono A, Miwa S (1991). "cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384----Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia". Proc. Natl. Acad. Sci. U.S.A. 88 (18): 8218–21. doi:10.1073/pnas.88.18.8218. PMC 52478. PMID 1896471.
- Neubauer B, Lakomek M, Winkler H, et al. (1991). "Point mutations in the L-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency". Blood. 77 (9): 1871–5. PMID 2018831.
- Tani K, Fujii H, Nagata S, Miwa S (1988). "Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells". Proc. Natl. Acad. Sci. U.S.A. 85 (6): 1792–5. doi:10.1073/pnas.85.6.1792. PMC 279865. PMID 3126495.
- Satoh H, Tani K, Yoshida MC, et al. (1988). "The human liver-type pyruvate kinase (PKL) gene is on chromosome 1 at band q21". Cytogenet. Cell Genet. 47 (3): 132–3. doi:10.1159/000132530. PMID 3378452.
- Baronciani L, Beutler E (1995). "Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia". J. Clin. Invest. 95 (4): 1702–9. doi:10.1172/JCI117846. PMC 295683. PMID 7706479.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Kanno H, Ballas SK, Miwa S, et al. (1994). "Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish". Blood. 83 (8): 2311–6. PMID 8161798.
- Lenzner C, Nürnberg P, Thiele BJ, et al. (1994). "Mutations in the pyruvate kinase L gene in patients with hereditary hemolytic anemia". Blood. 83 (10): 2817–22. PMID 8180378.
- Kanno H, Fujii H, Tsujino G, Miwa S (1993). "Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: a single amino acid substitution near the active site and decreased mRNA content of the R-type PK". Biochem. Biophys. Res. Commun. 192 (1): 46–52. doi:10.1006/bbrc.1993.1379. PMID 8476433.
- Kanno H, Fujii H, Miwa S (1993). "Low substrate affinity of pyruvate kinase variant (PK Sapporo) caused by a single amino acid substitution (426 Arg-->Gln) associated with hereditary hemolytic anemia". Blood. 81 (9): 2439–41. PMID 8481523.
- Baronciani L, Beutler E (1993). "Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia". Proc. Natl. Acad. Sci. U.S.A. 90 (9): 4324–7. doi:10.1073/pnas.90.9.4324. PMC 46499. PMID 8483951.
- Baronciani L, Bianchi P, Zanella A (1996). "Hematologically important mutations: red cell pyruvate kinase". Blood Cells Mol. Dis. 22 (1): 85–9. doi:10.1006/bcmd.1996.0012. PMID 8807089.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.